(AGTC)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

AGTC Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2022-11-30 Rosen James director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 Rosen James director 0 U-Tender D 1,000 0.00 0.00
2022-11-30 VANLENT ANNE director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 Robinson James A. Jr. director 0 D-Return D 25,000 2.17 54,250.00
2022-11-30 Aliski William director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 Aliski William director 0 U-Tender D 8,500 0.00 0.00
2022-11-30 Koenig Scott director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 Koenig Scott director 0 U-Tender D 34,246 0.00 0.00
2022-11-30 Hashad Yehia director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 HURWITZ EDWARD director 0 D-Return D 14,000 2.17 30,380.00
2022-11-30 HURWITZ EDWARD director 0 U-Tender D 1,800 0.00 0.00
2022-11-30 Washer Susan B. director, officer: President and CEO 0 D-Return D 442,000 0.40 176,800.00
2022-11-30 Washer Susan B. director, officer: President and CEO 0 U-Tender D 143,021 0.00 0.00
2022-11-30 Lieber Jonathan I officer: Chief Financial Officer 0 D-Return D 154,700 0.40 61,880.00
2022-11-30 Schneider Susan officer: Chief Medical Officer 0 D-Return D 142,300 0.40 56,920.00
2022-11-30 DOyley-Gay Hope officer: General Counsel 0 D-Return D 147,900 0.40 59,160.00
2022-11-30 Potter Stephen W officer: Chief Business Officer 0 D-Return D 133,100 0.40 53,240.00
2022-11-30 Potter Stephen W officer: Chief Business Officer 0 D-Return D 133,100 0.40 53,240.00
2022-11-30 Potter Stephen W officer: Chief Business Officer 8,750 U-Tender D 47,133 0.00 0.00
2022-11-30 Scaria Abraham officer: Chief Scientific Officer 0 D-Return D 124,500 0.40 49,800.00
2022-11-30 Reynolds Gerald Anthony officer: Chief Accounting Officer 0 D-Return D 34,500 3.70 127,650.00
2022-11-30 Reynolds Gerald Anthony officer: Chief Accounting Officer 0 D-Return D 34,500 3.70 127,650.00
2022-11-30 Reynolds Gerald Anthony officer: Chief Accounting Officer 42,500 U-Tender D 8,506 0.00 0.00
2022-08-21 Reynolds Gerald Anthony officer: Chief Accounting Officer 51,006 A-Award A 30,000 0.00 0.00
2022-08-21 Potter Stephen W officer: Chief Business Officer 133,100 A-Award A 133,100 0.40 53,240.00
2022-08-21 DOyley-Gay Hope officer: General Counsel 147,900 A-Award A 147,900 0.40 59,160.00
2022-08-21 Scaria Abraham officer: Chief Scientific Officer 124,500 A-Award A 124,500 0.40 49,800.00
2022-08-21 Schneider Susan officer: Chief Medical Officer 142,300 A-Award A 142,300 0.40 56,920.00
2022-08-21 Lieber Jonathan I officer: Chief Financial Officer 154,700 A-Award A 154,700 0.40 61,880.00
2022-08-21 Washer Susan B. director, officer: President and CEO 442,000 A-Award A 442,000 0.40 176,800.00
2022-07-01 Potter Stephen W officer: Chief Business Officer 55,883 S-Sale D 8,070 0.77 6,250.22
2022-05-27 Reynolds Gerald Anthony officer: Chief Accounting Officer 21,006 S-Sale D 3,994 0.85 3,375.73
2022-02-18 Washer Susan B. director, officer: President and CEO 0 M-Exempt D 120,686 0.35 42,240.10
2022-02-18 Washer Susan B. director, officer: President and CEO 143,021 S-Sale D 9,950 2.18 21,691.00
2022-02-18 Washer Susan B. director, officer: President and CEO 152,971 M-Exempt A 120,686 0.35 42,240.10
2021-12-13 DOyley-Gay Hope officer: General Counsel 180,000 A-Award A 180,000 2.02 363,600.00
2021-12-06 Scaria Abraham officer: Chief Scientific Officer 220,000 A-Award A 220,000 1.98 435,600.00
2021-11-30 Robinson James A. Jr. director 25,000 A-Award A 25,000 2.17 54,250.00
2021-11-30 VANLENT ANNE director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 Rosen James director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 Magovcevic-Liebisch Ivana director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 Koenig Scott director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 HURWITZ EDWARD director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 Hashad Yehia director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-30 Aliski William director 14,000 A-Award A 14,000 2.17 30,380.00
2021-11-08 Schneider Susan officer: Chief Medical Officer 180,000 A-Award A 180,000 2.76 496,800.00
2021-11-01 Washer Susan B. director, officer: President and CEO 0 M-Exempt D 3,877 3.50 13,569.50
2021-11-01 Washer Susan B. director, officer: President and CEO 32,285 M-Exempt A 3,877 3.50 13,569.50
2021-09-20 Lieber Jonathan I officer: Chief Financial Officer 202,000 A-Award A 202,000 3.30 666,600.00
2021-08-16 Hashad Yehia director 25,000 A-Award A 25,000 3.42 85,500.00
2021-08-15 Potter Stephen W officer: VP and Chief Business Officer 63,953 F-InKind D 5,724 3.58 20,491.92
2021-08-05 Reynolds Gerald Anthony officer: Chief Accounting Officer 34,500 A-Award A 34,500 3.70 127,650.00
2021-07-27 Washer Susan B. director, officer: President and CEO 275,000 A-Award A 275,000 3.74 1,028,500.00
2021-07-27 Potter Stephen W officer: VP and Chief Business Officer 60,000 A-Award A 60,000 3.74 224,400.00
2021-06-17 Potter Stephen W officer: VP and Chief Business Officer 69,677 A-Award A 35,000 0.00 0.00
2020-12-16 Koenig Scott director 12,000 A-Award A 12,000 4.72 56,640.00
2020-12-16 Aliski William director 12,000 A-Award A 12,000 4.72 56,640.00
2020-12-16 HURWITZ EDWARD director 12,000 A-Award A 12,000 4.72 56,640.00
2020-12-16 Magovcevic-Liebisch Ivana director 12,000 A-Award A 12,000 4.72 56,640.00
2020-12-16 Rosen James director 12,000 A-Award A 12,000 4.72 56,640.00
2020-12-16 VANLENT ANNE director 12,000 A-Award A 12,000 4.72 56,640.00
2020-08-15 Shearman Mark S officer: Chief Scientific Officer 33,277 F-InKind D 5,723 5.77 33,021.71
2020-08-15 Potter Stephen W officer: VP and Chief Business Officer 34,677 F-InKind D 5,723 5.77 33,021.71
2020-08-05 Shearman Mark S officer: Chief Scientific Officer 50,000 A-Award A 50,000 5.50 275,000.00
2020-08-05 Washer Susan B. director, officer: President and CEO 169,000 A-Award A 169,000 5.50 929,500.00
2020-08-05 Sullivan William A. officer: Chief Financial Officer 50,000 A-Award A 50,000 5.50 275,000.00
2020-08-05 Potter Stephen W officer: VP and Chief Business Officer 50,000 A-Award A 50,000 5.50 275,000.00
2019-12-26 Krol Patrick Johan Hendrik 10 percent owner 1,780,762 S-Sale D 81,162 5.24 425,288.88
2019-12-04 HURWITZ EDWARD director 10,000 A-Award A 10,000 3.02 30,200.00
2019-12-04 Rosen James director 10,000 A-Award A 10,000 3.02 30,200.00
2019-12-04 VANLENT ANNE director 10,000 A-Award A 10,000 3.02 30,200.00
2019-12-04 Koenig Scott director 10,000 A-Award A 10,000 3.02 30,200.00
2019-12-04 Magovcevic Ivana director 10,000 A-Award A 10,000 3.02 30,200.00
2019-12-04 Aliski William director 10,000 A-Award A 10,000 3.02 30,200.00
2019-11-19 Krol Patrick Johan Hendrik 10 percent owner 1,861,924 P-Purchase A 2,544 2.79 7,097.76
2019-09-18 Washer Susan B. director, officer: President and CEO 28,408 M-Exempt A 5,700 3.50 19,950.00
2019-09-18 Washer Susan B. director, officer: President and CEO 13,841 M-Exempt D 5,700 3.50 19,950.00
2019-08-15 Washer Susan B. director, officer: President and CEO 100,000 A-Award A 100,000 3.00 300,000.00
2019-08-15 Shearman Mark S officer: Chief Scientific Officer 39,000 A-Award A 39,000 0.00 0.00
2019-08-15 Shearman Mark S officer: Chief Scientific Officer 52,000 A-Award A 52,000 3.00 156,000.00
2019-08-15 Potter Stephen W officer: VP and Chief Business Officer 40,400 A-Award A 39,000 0.00 0.00
2019-08-15 Potter Stephen W officer: VP and Chief Business Officer 52,000 A-Award A 52,000 3.00 156,000.00
2019-08-15 Sullivan William A. officer: Chief Financial Officer 52,000 A-Award A 52,000 3.00 156,000.00
2019-08-15 Krex Brian officer: General Counsel 13,000 A-Award A 13,000 3.00 39,000.00
2019-07-29 Heah Theresa officer: Chief Medical Officer 100,000 A-Award A 100,000 3.91 391,000.00
2019-07-29 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 100,000 A-Award A 100,000 3.91 391,000.00
2019-07-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 56,644 A-Award A 2,000 0.00 0.00
2019-07-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 56,052 F-InKind D 592 3.75 2,220.00
2019-06-11 Feinsod Matthew officer: Interim Chief Medical Officer 54,644 F-InKind D 685 3.70 2,534.50
2019-06-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 55,329 A-Award A 2,000 0.00 0.00
2019-05-28 Koenig Scott director 0 M-Exempt D 32,018 0.35 11,206.30
2019-05-28 Koenig Scott director 34,246 M-Exempt A 32,018 0.35 11,206.30
2019-05-13 Feinsod Matthew officer: Interim Chief Medical Officer 53,329 F-InKind D 685 4.06 2,781.10
2019-05-13 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 54,014 A-Award A 2,000 0.00 0.00
2019-04-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 52,620 A-Award A 2,000 0.00 0.00
2019-04-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 52,014 F-InKind D 606 4.61 2,793.66
2019-03-25 Krex Brian officer: General Counsel 125,000 A-Award A 125,000 4.20 525,000.00
2019-03-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 51,287 A-Award A 2,000 0.00 0.00
2019-03-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 50,620 F-InKind D 667 3.97 2,647.99
2019-02-11 Feinsod Matthew officer: Exec. VP, Global Strat. & Dev. 50,078 A-Award A 2,000 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.